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Calcium phosphates (CaPs) have been widely used in the field of biomedical engineering
as bone graft substitutes or as carriers for drug delivery applications. Recent
developments have focused on combining CaPs with proteins to obtain functional
biomaterials that accommodate a broader spectrum of functional requirements. Silk
sericin was considered an unutilized protein by-product from the textile industry,
generating tons of residues every year. However, much effort has been dedicated to its
recovery after being associated with numerous biological properties such as antioxidant,
antibacterial, anti-coagulation and regenerative activities. In the past years, sericin has
also demonstrated to be suitable as a template for CaPmineralization. The present review
focuses on the recent developments for the production of sericin/CaP composites,
exploring their potential applications in bioengineering and opening new avenues in
other research fields such as in the cosmetic, food and environmental sectors. In
addition, this paper can also be useful as a guideline to design future research based
on sericin/CaP biomaterials.
Keywords: biomaterials, bone tissue engineering (bone-TE), calcium phosphates (CaPs), drug delivery,
hydroxyapatite (HAp), sericin
INTRODUCTION
Bone matrix consists of both a non-mineralized organic component (∼20% of the wet weight) and
a mineralized inorganic component (∼65–70%), composed mainly by collagen and carbonated
calcium phosphate (CaP) crystals, respectively. Crystallographic c-axis of these crystals are
arranged parallelly to the longitudinal axis of the fibrous protein, forming a tough and flexible
nanocomposite structure (Fuchs et al., 1997; Amini et al., 2012).
Accordingly, calcium phosphates (CaPs) from natural or synthetic nature, are widely used
in bone-related applications due to their biocompatibility, low density, chemical stability and
crystallinity (Vallet-Regí and González-Calbet, 2004). Among existing CaPs, hydroxyapatite (HAp)
is the most studied biomaterial due to its close similarity to human hard tissue in terms of
morphology and composition (Habraken et al., 2016).
In a quest to mimic bone tissue, several studies have focused on the synthesis of CaP composites
using synthetic polymers [polyglycolic acid (PGA), poly L-lactic acid (PLLA), polylactic-coglycolic
acid (PLGA), and polycaprolactone (PCL)] (Rezwan et al., 2006; Lee and Yuk, 2007; Chen
et al., 2014), natural polymers (alginate, chitosan, cellulose) (Pighinelli and Kucharska, 2013;
Cardoso et al., 2014; Salama, 2019), proteins (collagen, fibrin, keratin, and silk fibroin) (Dias
et al., 2010; Bleek and Taubert, 2013; Brown and Barker, 2014; Liu, 2015; Farokhi et al., 2018),
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or combinations of the foregoing (Chen et al., 2014). Synthetic
polymers may induce local and systemic host reactions due to the
release of chemicals and monomers from polymer degradation,
while natural polymers may lead to products with different
characteristics due to the differences in rawmaterials (Chen et al.,
2014).
Proteins have demonstrated to regulate the size, particle
size distribution, morphology, and assembly method of
nanostructured CaPs, being thus used to fabricate novel
materials with biomimetic characteristics for hard tissue
repair (Cai and Yao, 2010; Chen et al., 2014). Further, their
natural origin confers unique biocompatibility, versatility, and
biodegradability properties (Swetha et al., 2010). Collagen
has been conventionally used in the synthesis of organic/CaP
composites. Although collagen/CaP composites have a greater
similarity to natural bone, the clinical application of collagen-
type biomaterials is still limited due to its high cost, increased
risk of cross-infection and fast degradability (Chen et al., 2014).
Alternative protein systems can play a pivotal role during the
mineralization of CaP, as a binding-matrix. Keratin/CaP and
fibrin/CaP composites have biocompatibility and bioactivity
properties suitable for bone tissue engineering. However,
these biomaterials lack mechanical properties and processing
properties, and have fast biodegrability (Gsib et al., 2017;
Shavandi et al., 2017).
In this context silk is a valuable alternative due to its excellent
intrinsic properties such as non-toxicity, biodegradability,
self-assembly, mechanical stability and controllable structure
(Altman et al., 2003; Ha et al., 2013). In nature, silk-like proteins
are produced by several organisms such as silkworms, spiders,
mollusks, scorpions, bees, and ants (Holland et al., 2019). The
use of silk from the domesticated silkworm Bombyx mori is
well-established as suitable for biomedical applications due to
its abundance, batch-to-batch stability, and clinical track record
(Ude et al., 2014). This type of silk comprises a fibrous semi-
crystalline silk core, silk fibroin, which is mainly responsible
for the load-bearing capacity, and an outer layer of a globular
protein, sericin, which serves as gluing agent and has a protective
function. While fibroin is processed in large scale in the textile
industry, sericin is a by-product generated during this process, in
the so-called degumming procedure (Mondal et al., 2006).
Silk fibroin has been widely used and investigated for
applications such as sutures (Saxena et al., 2014), artificial
ligaments (Farè et al., 2013), tissue engineering constructs
(Kasoju and Bora, 2012), and substrates for cell culture (Liu
et al., 2012). Fibroin/CaP composites have been reported and are
considered suitable for load bearing applications (Yan et al., 2013;
Farokhi et al., 2018).
Silk sericin, on the other hand, was until recently considered
unfit for biomedical use. Of 1 million tons of silkworm
cocoons produced each year worldwide, ∼50,000 t of sericin
are generated, leading to environmental and economic concerns
(Aramwit et al., 2012b). This protein, in its native state, was
found to elicit immune and allergic responses when present in
virgin silk sutures (Soong andKenyon, 1984). However, emerging
evidence suggests that extracted sericin per se is biocompatible,
similarly to silk fibroin or collagen (Chirila et al., 2013; Lamboni
et al., 2015). Therefore it has been gaining reputation in the
biomedical field with several works showing its potential, as
revised elsewhere (Kunz et al., 2016; Ahsan et al., 2018). Thus,
the use of sericin/CaP composites not only reduces the inherent
environmental impact of sericin disposal but also allows the
development of new functional biomaterials. This silk protein
increases antioxidant, anti-tyrosinase and anti-inflammatory
activity; stimulates collagen production, tumor inhibitory effects;
induces the nucleation of bone-like CaPs; and promotes stability
and prolonged release in drug delivery systems (Aramwit, 2014;
Lamboni et al., 2015).
The molecular weight distribution and even the amino acid
composition of sericin were found to be dependent on the
extraction method used (Yang et al., 2014c; Kunz et al., 2016).
Sericin consists of 18 amino acids, among which serine, histidine,
glutamic acid, aspartic acid, threonine, and tyrosine are normally
present in higher percentages. Thus, this protein is highly
hydrophilic and its molecular weight can range from 20 to
400 kDa (Kunz et al., 2016). Its polar side chains have several
functional groups (carboxyl, amine, hydroxyl) responsible for
moisturizing and oxidizing properties, allowing the interaction
with other compounds through crosslinking, copolymerization
or blending to form improved biomaterials (Ahsan et al.,
2018). According to the literature, amino acids can highly
influence the mineralization process of CaPs. Glutamic acid and
aspartic acid play a critical role in controlling HAp nucleation
and growth, by attracting calcium and phosphate ions and
consequently increasing the local supersaturation, which results
in the development of crystals. Histidine and other negatively
charged amino acids are involved in HAp nucleation within
extracellular matrix proteins (George and Veis, 2008; Tavafoghi
and Cerruti, 2016).
Sericin mainly adopts the form of an amorphous random
spiral and may also present the form of a β-sheet organized
structure. The random spiral easily acquires β-sheet
conformation as a consequence of moisture absorption and
mechanical elongation, forming a denser, organized, crystalline
and less soluble structure. If the protein is dissolved in hot water
and subsequently undergoes a temperature decrease, its random
coil structure becomes β-sheet, acquiring a gelatinous form
(Chen et al., 2015). That is, with the change in temperature the
conformation of the protein changes. Upon heating the sericin
dissolves in solution, upon cooling the sericin solution jellifies
(Sol-Gel properties; Kunz et al., 2016).
SILK SERICIN/CALCIUM
PHOSPHATE-BASED MATERIALS
Recently, sericin has demonstrated to be suitable as a template
for CaPmineralization. In the literature, sericin/CaP biomaterials
are usually synthetized by wet mechanochemical processes,
where mineralization occurs by spontaneous nucleation (Cai
et al., 2009, 2010) or using a surface as template (Takeuchi
et al., 2005b; Yang et al., 2014a). The resulting composites
generally present a poor crystallinity and the size of the particles
generated can range from 20 to 500 nm in length to 3–80 nm
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in width (Cai et al., 2009, 2010; Veiga et al., 2019). The
influence of several experimental conditions on the formation
of these sericin/CaPs has been studied by several authors,
namely different sericin extraction and storage procedures,
mineralization time, sericin concentration, and temperature
(Table 1). In the works of Takeuchi et al. (2003a, 2005b), sericin
was obtained by extraction in boiling water, using different
temperatures and storage procedures. It was found that high
molecular weight sericin and β-sheet structure induces apatite
deposition. These conditions were achieved for higher extraction
temperatures and sericin storage. It is well-known that the
extraction method used influences the molecular weight and the
amino acid concentration of sericin, which results in different
physical and biological properties (Kunz et al., 2016). According
to Aramwit et al. (2010), extraction in boiling water is the
least toxic procedure to cells and activates the highest collagen
production. Acid, alkaline, and urea extraction methods can also
be used to obtain sericin that promotes the formation of bone
organic matrix. However, these approaches can result in toxicity
at higher sericin concentrations (Padamwar and Pawar, 2004).
Moreover, acid and alkaline methods have a degrading effect on
proteins and considerably increase its solubility. Although urea
and enzymatic methods can be used to obtain unchanged sericin,
the procedures are expensive and time consuming. On the other
hand, hot-water extraction is a simple and environmentally
friendly method that preserves the main characteristics of silk
sericin (Gulrajani et al., 2000; Dash et al., 2008).
As for the influence of the mineralization time on apatite
deposition, it was found that the optimum days for growth of
nano HAp crystals with low crystallinity is 7 days. In contrast,
after 30 days, the size of HAp crystals increases, and other CaP
phases are formed (Sukjai et al., 2012). Further, it was also
shown that nucleation of HAp mediated by sericin is a gradual
process, since nanoneedle crystals with low crystallinity are only
grown after at least 24 h of mineralization (Yang et al., 2014b).
In the work of Zhang et al. (2014), the same conclusions were
drawn for ethanol-treated sericin films immersed in SBF. A
three-dimensional (3D) structure with globular carbonate apatite
particles was observed after 7 days. Further, rigid and brittle
properties of the film increased with mineralization time, since
apatite particles were increasingly being deposited. While the
elastic modulus increased significantly after 5 and 7 days (23.027
± 0.83 to 57.02 ± 1.04 MPa), the tensile strength (day 1: 1.58
± 0.53, day 7: 0.24 ± 0.18) and the elongation at break of the
3D film decreased (day 1: 112.83± 49.02%, day 7: 2.01± 1.81%).
The increase of themineralization time and sericin concentration
was also reported to lead to an increase in the mean particle
size of the particles synthetized (Cai et al., 2009). The recent
developments in sericin/CaP composites and its potential for
biomedical applications is presented in the next section.
RESEARCH APPLICATIONS
Biomineralization
Although proteins play a crucial role during mineral formation
in biological systems, the biomineralization process is still far
from being understood (Subburaman et al., 2006). Therefore,
most studies on sericin/CaP composites focus on contributing to
the understanding of this phenomenon. Sericin/CaP nanoparticle
systems obtained are generally nanorod-like crystals with poor
crystallinity. Further, sericin promotes crystal growth of HAp
along the c-axis, resembling natural biomineralization. Although
in the work of Cai et al. (2010), HAp particles similar to mineral
bone were achieved in the absence of sericin, this was only
verified for specific temperature and pH conditions. Other works
argue that the presence of sericin promotes a homogeneous
assembly of HAp, under several experimental conditions (Cai
et al., 2009; Yang et al., 2014b). The proposed mechanisms
for the assembly of CaP crystals in the presence of sericin are
usually based on changes in the protein conformation. When
dissolved, sericin adopts an amorphous structure in which the
hydrophilic sidechains are exposed. However, when submitted to
different triggers (e.g., mechanical stretching properties, moisture
absorption, temperature, dehydration, or using crosslinking
agents), changes in random coil structure for β-sheet easily occur
(Teramoto and Miyazawa, 2003; Nayak et al., 2012; Kunz et al.,
2016).
According to Takeuchi, the induction sites for HAp nucleation
in sericin films are governed by the arrangement of carboxyl
groups on the protein (Takeuchi et al., 2005b). When a protein
acquires a β-sheet conformation, the amino acid side chains
alternate between the two faces of the sheet. Hydrophobic
side-chains point in one direction and polar side-chains in
the other, which can explain orientation of functional groups
in β-sheet sericin (Boyle, 2018). For sericin/HAp particles,
the presence of chelated calcium ions in the precipitation
medium provides nucleation sites. The formed HAp crystals are
rearranged along their c-axis by attaching to the sericinmolecular
chains (Cai et al., 2009).
The understanding of the biomineralization process can lead
to numerous applications in biomedical engineering, namely
for the development of advanced bone substitutes (Chen et al.,
2019; Veiga et al., 2019). Even though pure sericin has poor
mechanical properties, which hinders its utilization in bone tissue
engineering (bone-TE), its biological properties can promote
bone formation and induce the nucleation of bone-like HAp.
In fact, sericin/CaP materials have shown the ability to promote
cell differentiation and proliferation of bone marrow-derived
mesenchymal stem cells (BMSCs) and of human osteosarcoma
cells (MG-63; Table 1). Therefore, most of the developed works
on sericin/CaP focus on demonstrating the potential of these
composites in the field of bone-TE, as biomaterials for bone filling
and repair or as drug delivery systems for tumor therapy, as
illustrated in Figure 1.
Bone Tissue Engineering
Although some authors mention the potential of sericin/CaP as
scaffolds for TE (Takeuchi et al., 2003b; Yang et al., 2014b), an
ideal 3D scaffold should not only act as a template for tissue
growth and has controlled resorbability, but should also elicit a
regenerative effect and present adequatemechanical performance
over time (Canillas et al., 2017). As previously mentioned, the last
requirement is not fulfilled by using only sericin (Ahsan et al.,
2018).


































TABLE 1 | Articles on sericin/CaP biomaterials.
Objectives Methodology Experimental
conditions
Studied variables Physicochemical properties Biological properties Applications References
Investigate the
ability of natural






- Sericin extraction was
performed in boiling water
(105◦C, 1 h);
Soaking method:
- Cloths made of raw silk,
normal silk fiber, and






– - The deposition of apatite microspheres was
observed on both the surface of cloth made
from raw silk fiber and in the sericin films;
- CaP particles were not obtained on cloth
made from normal silk fibers;
- The apatite deposition on the raw silk fiber
cloth was accelerated by presence of


















- Sericin films were
immersed in 1.5 SBF.









105◦C 1 h/4◦C for 2
weeks: 105–2w;
120◦C 1 h/4◦C for 2
weeks: 120–2w.
- Molecular weight: 134, 106, 42, and 43 kDa
for 105–0 d, 105–2w, 120–0 d, and
120–2w, respectively;
- After storage for 2 weeks at 4◦C, β-sheet
structure became dominant;
- Spherical HAp particles with low crystallinity
were only observed on the surface of















- Sericin coated silk fibers
and non-sericin coated
silk fibers were used were
soaked in SBF of
various concentrations.




- In non-sericin coated silk fibers, flat shape
CaP crystals were formed after 7 days. With
the increase in SBF concentration, cauliflower
shape HAp crystals were obtained;
- In sericin coated silk fibers only cauliflower
shape HAp crystals were formed for 1.0 SBF














- Sericin (wt.%) = 8,
extraction was performed
in boiling water for 30min;
- The sericin film was
soaked in 90%
(v/v) ethanol;
- Alternative soaking of the





T = 37 ◦C.
Immersion cycles: 5,
10, 15 cycles.
- When the cycles of dip coating were set to
be 5, 10, and 30, respectively, aggregation
appeared on the coating and apatite
spherical crystals were increased;
- The coating thickness increased by
increasing cycles of dip coating.
- In vitro assays showed that the
HAp/sericin composites
obtained have higher cell
adhesion and growth activity of


























































































TABLE 1 | Continued
Objectives Methodology Experimental
conditions




sericin film in SBF.
Sericin (wt.%) = 9,
extraction was performed in
boiling water for 30min;
- The sericin film was
soaked in 40% (v/v)
ethanol;
Soaking method:
- The sericin/ethanol film
was immersed in 1.5 SBF.
pH 7.4;
T = 37 ◦C.
Mineralization time =1,
3, 5, or 7 days.
- With the increase in mineralization time, the
quantity of the deposited inorganic
substance increased, showing a 3D
aggregated structure;
- After 7 days globular carbonate apatite
particles with low crystallinity were observed
(initial thickness = 93.5 ± 728.7µm;
thickness after 7 days: 6.22 ± 2.13mm).
In vitro assays showed that the
sericin/HAp composites
obtained have higher cell viability
of human osteosarcoma MG-63






















Sericin (w/v%) = 0.001,




- Rod-like sericin/HAp composites were
obtained;
- The crystallinity of the composites is lower
when compared to HAp;
- Higher concentration of sericin led to the
synthesis of larger HAp particles—sericin
0.001% had the smallest size of 50–100 nm
in length and <20 nm in diameter, while
sericin 1% possessed the largest size of
300–500 nm in length and 50–80 nm in
diameter;
- Longer mineralization time led to an increase
of the crystallinity and size of the composites;
- Size of the crystals goes from 50 to 100 nm
in length and <20 nm in diameter; to
300–500 nm in length and 50–80 nm
in diameter.
In vitro assays showed that the
composites obtained have
higher cell differentiation and
proliferation of MG-63 cells,
when compared to HAp. Further,
composites with higher sericin
concentrarion had the highest






















pH: 7.4, 10, and 12. - A homogeneous assembly of HAp with an
enamel prism-like structure could be
obtained both in the presence of sericin and
in its absence (T =50◦C and pH 10);
- At pH 7.4, few aggregated nanoplates were
formed;
- When the pH value increased to 10, a large
amount of nanoparticle bundles was
obtained.
- At pH 12 the particles have a size of
150–250 nm in length and 50–80 nm in
width. The particles obtained have rod-like
morphology;
- All the particles have low crystallinity, being





















































































TABLE 1 | Continued
Objectives Methodology Experimental
conditions
Studied variables Physicochemical properties Biological properties Applications References







Sericin (mg/mL) = 0.5, 2,
and 8; extraction was
performed in boiling water
(120 ◦C for 30 min).
Co-precipitation method:
[Na2HPO4] (12mM);





6, 12, and 24 h.
- A higher concentration of sericin promotes
the formation of nanoneedle-like crystals;
- Nucleation of HAp mediated by sericin is a
gradual process;
- After 2 h, a clump of starfish- like crystals
was randomly scattered;
- After 6 h, spherical crystals were formed and
aggregated;
- After 12 h, spindly crystals were heavily
aggregated;
- After 24 h nanoneedle crystals with 20–40 nm
in length and 3–5 nm in width were obtained.






























time: ≈ 2 h 30min.
Sericin (g/L) = 0.1, 1,
extraction was
performed in boiling
water (1 h, 150 rpm).
- The synthesized particles are single-phased
nanometric HAp with low crystallinity;
- The increase in sericin concentration is
associated with decreased crystallinity;
- Sericin/HAp composites have a higher mean
particle size when compared to HAp. Further,
the increase in sericin concentration leads to
a size increase (Hap-−0.070µm; sericin 0.1
g/L-−0.105µm; sericin 1 g/L-−0.116µm.);
- The increase in sericin concentration also
leads to the formation of more particles with
a plate-like structure.
In vitro assays showed that the
sericin/HAp composites
obtained do not elicit a cytotoxic
response on human primary cells
(HNDFs) and that at high
concentrations (100 mg/mL)
elicit a lower cytotoxic response












Sericin (g/L) = 2, purchased
from Aotesi Biochemicals
Co. Ltd (Huzhou, China).
Co-precipitation method:
[Na2CO3] (0.2 mol/L);
CaCl2 (0.2 mol/L) + sericin.
T = 20◦C. Mineralization time =
10, 20, 30, 40, and
50min.
- With the increase in the mineralization time,
the crystal phase of CaCO3 transferred from
calcite dominated to vaterite dominated
mixtures;
- The morphology of CaCO3 changed from
disk-like calcite crystal to spherical vaterite
crystal, the products with the reaction time of
10min are mainly disk-like crystals and little
spherical and cube-like crystals (5–15µm).
After 20min small thorn spherical aggregates
of rhombic crystal (with the diameter of
6–7µm) and lamellar structured crystal (with
the size of 3–4µm) are formed. After 30 and
40min flower-like crystals with the size of
4–5µm and partly ellipsoidal crystals 5–6µm
in length and 2–3µm in width and polyhedral
structure of 3–4µm are formed. After 50min






















































































TABLE 1 | Continued
Objectives Methodology Experimental
conditions








Sericin = 2 g/L, purchased
from Aotesi Biochemicals
Co. Ltd (Huzhou, China).
Precipitation method:
1◦) Synthesis of CaCO3
particles through a co-
precipitation method:















Ca and P ratios of
1:0.15, 1:0.3, 1:0.45,
1:2.5;
Mineralization time = 1,
3, 5, 10, 15min;
Microwave powers =
160, 320, 480, 640,
and 800W.
- Weight percentages of HAp in the
composites are 19, 25, 40, 45, and 56%
corresponding to the microwave power
values of 160, 320, 480, 640, and 800W,
respectively;
- With the increase of Ca/P ratio in the reaction
solution from 1:0.15, 1:0.30, 1:0.45, 1:2.5 to
1:7, the content of HAp in the composite
increases from 0.8, 1.4, 12.3, 50.0 to 99.0%;
- The composite with higher HAp content
showed a slower degradation speed;
- The average diameter of the spherical
particles is about 6.7µm, which is close to
















Sericin (g/L) = 2, purchased
from Aotesi Biochemicals
Co. Ltd (Huzhou, China);
1◦) Synthesis of CaCO3
particles through a co-
precipitation method:
- [CaCl2] (0.2M) + sericin;
2◦) Addition of [Na2HPO4]
(0.2M);
3◦) Synthesis of HAp
particles using a
hydrothermal method:



















60◦C for 48 h.
Time in the autoclave =
2, 4, 8, and 16 h.
- The sericin/CaCO3/HAp particles obtained
are homogeneous microspheres with a size
distribution from 3 to 10µm;
- Uniform porous HAp microspheres with high
crystallinity were obtained:
- Increasing time in the autoclave has little
impact on morphology of sample but results
in more rough surfaces.
- In vitro assays showed that the
sericin/CaCO3/HAp
composites obtained are not
toxic to MG-63 cells and have
similar proliferation rates.
Further, with the increase in
HAp content higher cell viability
was observed.




implanted into the groin
subcutaneous tissue, using
colloidal sodium alginate
solution as a carrier.
Additionaly, sericin/CaCO3















- Sericin was obtained by
extraction in boiling water.






Aldrich Chemicals Pvt Ltd;





– - The particles obtained have a heterogeneous
size distribution and different morphologies.
- In vitro assays showed that the
sericin/monite composites do
not elicit hemolysis of human
blood. Further, the composites
present cell viability and
osteogenic properties and

























































































TABLE 1 | Continued
Objectives Methodology Experimental
conditions













[CaCl2] (50mM) + sericin.
pH = 9–10;
T = 50◦C.
– - The sericin/CaP materials obtained adopt a
spherical morphology with an average
diameter of 80 nm;
- The particles have a smooth surface and a
low degree of crystallinity.
In vivo tests evaluated the
distribution, degradability and
tumor targeting of the
sericin/CaP composites;
- Distribution of sericin/CaP
nanoparticles in vivo were
mostly verified in the liver of
mice;
- The degradation time did not
increase linearly with the
amount of sericin/CaP
nanoparticles injected in vivo;
- Nanoparticles with an average
size of 80 nm can achieve
tumor localization at 7 days





field of bone tissue
engineering (for















were obtained mixing the
sericin solution with
[CaCl2] (30mM) and by
the posterior addition of
amylum (0.5%);
Soaking method:
- The sericin microcapsules







– Mineralization time: 3,
5, 6.5, and 12 h;
In vitro amylum release
at different pH values:
3, 5, 7, and 9;
T = 37◦C;




0, 0.1, 0.4, and 0.7M.
- An increase in the mineralization time led to
an increase of the crystallinity and thickness
of the microcapsules; Particles in the surface
of the microparticles with a CaP salt-based
composition and flake-like morphology after
12 h;
- When the pH value was 3 the amylum release
rate was slow for the sericin microcapsules
and the release amount increased gradually.
After 100 h, the release rate decreased, and
the release amount did not increase. pH 5
and 7 with similar behavior, characterized by
a faster release rate. At pH 9, the composite
became unstable;
- The release rate was very fast when the
concentration of NaCl in the
controlled-releasing solution was 0.7M at
37◦C, being slower for other concentrations.
Further, at lower pH values sericin/CaP
microspheres release rate was rather slower
when compared to sericin microspheres.
In vitro assays showed the
composites promote the viability
and proliferation of HapG-2 cells,



















Sericin was extracted from
raw silk fiber by an
autoclave at 105◦C for
60min and stored at 4◦C for
2 weeks.
Soaking method:
- A α-TCP block was
soaked into a
sericin solution.
– – – In vivo tests showed that after 4
weeks of implantation on bone
defects made in rabbit tibiae and
subcutaneous sites of rabbit
backs, higher density of cortical
bone was estimated for α-TCP






field of bone tissue
engineering (for










































































































































































































































































































































































































































































































































































































































































































































































Therefore, sericin/CaP biomaterials can better perform
as, for instances, a particulate system for bone filling rather
than as a 3D regenerative material (Jones, 2013). Accordingly,
studies focus on the synthesis of sericin/CaP nanoparticles
(Cai et al., 2009), and films (Jones, 2013; Zhang et al., 2014).
Sericin/CaP nanoparticles have been described as suitable
for bone filling applications due to their biocompatibility,
biodegradation, strong ability to promote cell differentiation
and proliferation and possibility to deliver therapeutic medicine.
Sericin/CaP composite films have also potential in bone-
related applications, being biocompatible and promoting
cell viability. Further, both particles and films can be
used to for fundamental studies of cell–matrix interactions
(Table 1).
HAp is a relatively inert material that is retained in vivo
for prolonged periods of time due to its slow reabsorption
rate (Campana et al., 2014). Thus, sericin/HAp composites have
potential as coating in orthopedic or dental implants. This is
in agreement with the studies of Klein et al. (1991) and Dhert
et al. (1993) where it was found that, when used as a coating
material, HAp exhibits excellent bone contact with implanted
titanium prosthesis. By comparison, tricalcium phosphate (TCP)
materials give rise to more bone remodeling lacunae along the
implant surface (Klein et al., 1991). Additionally, it has also been
reported that the use of sericin can improve the osseointegration
and osteoconduction of orthopedic titanium implants (Nayak
et al., 2013), and that sericin/HAp composites have excellent
biocompatibility and cell viability (Yang et al., 2014a; Zhang et al.,
2014).
In contrast to HAp, TCP-based scaffolds are resorbable,
making TCP composites specially suitable for the treatment
of small bone defects (Bohner, 2000). In the study of
Chasono et al., a TCP-based material led to complete
new bone formation after 13–20 weeks of implantation
(Chazono et al., 2004). Also, TCP appears to have superior
osteoconductivity and bone remodeling, when compared
to HAp (Ogose et al., 2005). The co-precipitation of sericin
with TCP is demonstrated to decrease the degradation rate
and improve the biological performance. According to the
results of Takeuchi et al. (2005a), sericin/α-TCP materials
show slower degradation in bone defect of rabbits, when
compared to pure α-TCP. Other sericin/CaP composites,
such as sericin/HAp/calcium carbonate (CaCO3), have also
showed controllable degradability properties (Zhao et al.,
2013; Yang et al., 2016). In published works, the formation of
sericin/HAp composites, was achieved through the conversion
of sericin/CaCO3 particles using the assistance of microwave
irradiation (Yang et al., 2016) or via a hydrothermal method
(Zhong et al., 2016). A higher HAp content was also associated
with a slower degradation rate, being therefore appropriate for
bone regeneration.
In vivo experiments showed that dicalcium phosphate
anhydrous (DCPA), also known as monetite, can resorb faster
than most CaP, supporting implant replacement by newly
formed tissue (Tamimi et al., 2012). Thus, the sericin/monetite
synthetized by Vedakumari et al. (2019) has potential as
biodegradable materials.
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FIGURE 1 | Schematic representation of CaP mineralization process in the presence of sericin and research applications of sericin/CaP composites. Proposed
biomineralization mechanism based on the works of Takeuchi et al. (2005b), Cai et al. (2009), and Veiga et al. (2019). (A1) Sericin/HAp composite particles, (A2) cell
morphology and differentiation of MG-63 cells after 5 days of contact with the composite reproduced from Cai et al. (2009) with permission from Royal Society of
Chemistry; (B1) sericin/CaCO3 composite particles, (B2) mice tissue after 12 weeks of composite implantation reproduced from Zhong et al. (2016) with permission
from Elsevier Science & Technology Journals; (C1) sericin/CaP composite nanoparticles, (C2) distribution of the composite in vivo reproduced from Zhao et al. (2017)
with permission from John Wiley and Sons; (D1) sericin/HAp composite microcapsules, (D2) cell adhesion activity on HapG-2 cells after 7 days of contact with the
composite reproduced from Li et al. (2016) with permission from Royal Society of Chemistry.
Drug Delivery Systems
Sericin/CaPs materials have also been proposed as drug delivery
systems. Due to their biodegradability and hydrophilicity sericin-
based materials may be used as a vehicle to deliver therapeutic
medicine (Wang et al., 2015). Ideally, these systems should have
controlled degradation, enable easy binding of other molecules
and have pH responsiveness (Kunz et al., 2016). Sericin/CaP
composites can be designed as microsystems with a good loading
and release capability for bioactive molecules to be applied in
TE or as an anti-tumor therapeutic system (Table 1). The drug
release potential of sericin/CaP microcapsules was studied in a
paper by Li et al. (2016), by incubating sericin microcapsules
with a supersaturated calcium phosphate solution containing
citric acid. The CaP shell protected the inner sericin structure,
and consequently the stored bioactive molecules until a pH
change occurs. Not only did the capsules showed an improved
stability and a longer storage time capability, but also increased
cell viability.
In the work of Zhao et al. (2017), sericin/CaP nanoparticles
were developed and injected into mice by intravenous injection,
to allow particle distribution through the whole body. Analysis
of the ex vivo organs showed that 80 nm spherical sericin/CaP
nanoparticles are almost completely distributed in the liver
cells of mice (≈90%) and can be biodegraded within 2 weeks.
However, the degradation rate is not proportional to the amount
of composites injected, as 100 and 200 µg of nanoparticles
were degraded after 48 h and 13 days, respectively. The targeting
percentage was 30% at 7 days post-injection. As no particles were
found in other organs, it was concluded that these composites can
target specific solid tumors in vivo.
Nowadays, nanoparticle pharmaceutical carriers are probably
amongst the most studied sericin/CaP composites, making these
very interesting composites in this field. The large surface
area/volume ratio provides the capability to load large amounts of
biomolecules and the ability to go across the cellular membrane
(Jia et al., 2013).
Other Applications
As the study of sericin/CaP composite materials is relatively
recent, there are still several areas to be explored, taking
advantage of the individual properties of sericin and CaP.
For instance, calcium has an important role in maintaining
homeostasis in mammalian skin, promoting wound healing
(Lansdown, 2002; Kawai et al., 2011). In particular calcium-based
nanoparticles have shown to have therapeutic benefits when
used in cutaneous wound repair (Kawai et al., 2011). On the
other hand, sericin has high antioxidant potential (Prasong, 2011;
Kumar and Mandal, 2017), antibacterial activity (Ramesan et al.,
2016), mitogenic effect on cells (Terada et al., 2005), potential to
inhibit inflammation (Aramwit et al., 2012a), and ability to retain
hydration (Padamwar et al., 2005). In the study of Aramwit et al.,
a sericin-based therapeutic cream formulation improved healing
by promoting collagen production and rapid re-epithelialization
in rat skin wounds (Aramwit et al., 2009, 2013). Both two-
dimensional (films) and three-dimensional (scaffolds) sericin
matrices, obtained using different blending methods, have been
reported for skin tissue repair (Nayak et al., 2012; Lamboni
et al., 2015; Karahaliloglu et al., 2017). Therefore, a sericin/CaP
biomaterial could significantly accelerate and improves wound
healing and soft tissue replacement. While sericin has been used
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in many cosmetic products over the years, CaP-based materials
are only recently being explored in this area. CaP particles can
be used as a bone filler in esthetical treatments for diminishing
wrinkles by stimulating conjunctive tissue formation (Lopes
et al., 2009). Due to its affinity for biopolymers, crystallites of
HAp in the dermis can promote the self-assembly of collagen
fibers, smoothing fine lines and even deeper wrinkles (Bell,
2012; Gupta et al., 2019). CaP-based sunscreens have also been
studied due to their biocompatible nature that does not generate
allergies and other skin irritations, contrary to many organic
sunscreens (de Araujo et al., 2010). These properties coupled
with sericin strong suppressing activity against UVB-induced
acute damage and tumor promotion (Zhaorigetu et al., 2003;
Kumar et al., 2018), anti-wrinkle effect and anti-tyrosinase
characteristics (Chlapanidas et al., 2013; Kumar and Mandal,
2019) justify the development of sericin/CaP biomaterials for the
cosmetic industry.
Different CaP phases are used in food applications, as a
supplement to increase calcium and phosphorus intake or as
food additives to thicken and stabilize firm foods (Eliaz and
Metoki, 2017). Phosphate additives are widely used in processed
foods as preservatives, acidifying agents, acidity buffers, and
emulsifying agents. Despite their applications, the use of non-
naturally occurring phosphates in food can negatively affect
the general health of the consumer. Synthetically produced
phosphates are effectively absorbed in the gastrointestinal tract,
whereas in “organic” phosphates, the absorption percentage
ranges between 40 and 60%. This can lead to calcification
in blood vessels and organs, being also potentially harmful
for patients with chronic kidney disease (Sherman, 2007; Ritz
et al., 2012). Studies show that sericin can be used to prevent
functional gastrointestinal disorders, improving ion absorption
and consequent bioavailability of these elements (zinc, iron,
magnesium, and calcium ions) and improving constipation
(Sasaki et al., 2000a,b). These characteristics can inspire the
synthesis of sericin/CaP materials also for the food industry.
Recent applications of sericin/CaP composites include the
removal of micro-pollutants from wastewater. In the work of
Koley et al. (2016), sericin/HAp materials were used to purify
water, exhibiting excellent adsorption of toxic heavy metal ions.
While HAp has stability, sericin is a water-soluble material,
capable of forming hydrogen bonds and with strong metal
binding properties (Khosa et al., 2014).
RECENT ADVANCES
Despite their properties of interest and numerous applications,
sericin/CaP composites still have disadvantages to circumvent
such as poor mechanical resistance under complex stress states.
CaPs and pure sericin have a low mechanical profile when
compared to bone tissue, which limits the application of
sericin/CaP composites as 3D biomaterials for load-bearing
applications (Kunz et al., 2016; Canillas et al., 2017). Of
the reviewed papers, only Zhang et al. (2014) reported the
mechanical properties of sericin/HAp composites, obtained by
mineralization of a flexible ethanol-treated sericin film. Other
explored alternatives to enhance these characteristics include the
integration of other components in the composite. Adding a
structural organic component such as collagen (Griffanti et al.,
2019; Jang et al., 2019), chitosan (Chen et al., 2015), and alginate
(Zhang et al., 2015); or a synthetic polymer such as polymethyl
methacrylate (PMMA) (Tontowi et al., 2017) are examples of
some of the most recent approaches. Structural integrity of the
constructs can also be obtained by cross-linking the components
with glutaraldehyde (GTA) (Bhowmick et al., 2016).
CONCLUSIONS
Up to recently, silk sericin was traditionally disposed during
silk processing. Nowadays, there has been a growing interest
in its recovery due to both its beneficial properties and
environmental impact caused by its generation. Works on
sericin/CaP composites focus mainly on understanding the
biomineralization process, through the study of the effect of
sericin in HAp nucleation. Other studies dedicate to the synthesis
of these biomaterials for the substitution and regeneration of
hard tissues and to the development of new drug delivery
systems. Apart from the biomedical field, there are other areas
where these composites have a lot of potential, such as in the
cosmetic, food an environmental sector.
In the last decade, the number of published papers on
sericin/CaP composites has increased substantially. Thus, in
the near future, it is clear that the integration of silk sericin
in CaP biomaterials will result in advanced composite systems
with evident benefits on several research fields, particularly in
biomedical and pharmaceutic-related applications.
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